Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial

Cited by (125)

Items 101–125 of 125

1. Research Advances in COPD Drugs and Novel Targets
   Lveli Wang, Chuang Xiao, Yaping Liang, Zhiying Weng, Weimin Yang · 2021 · Nano LIFE
2. Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial
   Robert A. Wise, Janet T. Holbrook, Gerard J. Criner, Sanjay Sethi, Sobharani Rayapudi, Kuladeep R. Sudini, Elizabeth A. Sugar, Alyce E. Burke, Rajesh Kumar Thimmulappa, Anju Singh et al. · 2017 · PLoS ONE
3. SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial
   Merete Bridget Long, Hani Abo-Leyah, Yan Hui Giam, Thenmalar Vadiveloo, Rebecca C Hull, Holly Rachael Keir, Thomas Pembridge, Daniela Alferes De Lima Headley, Lilia Delgado, Sarah Karen Inglis et al. · 2024 · ERJ Open Research
4. Sulforaphane Synergies with Phytochemicals and Pharmaceuticals: Implications for Healthspan
   Jed W. Fahey, Hua Liu · 2026 · Medicines
5. Recent understanding of immunometabolic remodeling in pulmonary macrophages: homeostasis, chronic respiratory diseases, and therapeutic targeting
   Zhenli Yuan, Ahmad Alhaskawi, Yejiang Tang, Bing Ruan · 2026 · Frontiers in Pharmacology
6. Eat4Genes: a bioinformatic rational gene targeting app and prototype model for improving human health
   Morgan L. Ford, Jessica M. Cooley, Veda Sripada, Zhengwen Xu, John S. Erickson, Kristin P. Bennett, Dana R. Crawford · 2023 · Frontiers in Nutrition
7. Role of Oxidative Stress in Complexity of Respiratory Diseases
   Maliheh Ghadiri, Amanda Eugenia Yung, Mehra Haghi · 2020 · Springer eBooks
8. Role of Oxidative Stress Induced by Cigarette Smoke in the Pathogenicity of Chronic Obstructive Pulmonary Disease
   Anuradha Ratna, Shyamali Mukherjee, Salil K. Das · 2019 · Springer eBooks
9. OXIDATIVE STRESS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
   Peter John Barnes · 2025 · Wiley eBooks
10. Sulforaphane Attenuates PM 2.5 ‐Induced Chronic Obstructive Pulmonary Disease by Modulation of Nrf2 Activating and EGFR / PI3K / AKT Signaling
    Qi Lin, Xirong Wu, Shiya Wu, Jianshao Mao, Mengmeng Deng, Xinyan Liao, Chaofeng Zhang · 2026 · Phytotherapy Research
11. Diet and Lung Health
    Foteini Malli, Themis Koutsioukis, George Pounis, Konstantinos I. Gourgoulianis · 2018 · Elsevier eBooks
12. Assessing Bioavailability and Bioactivity of 4-Hydroxythiazolidine-2-Thiones, Newly Discovered Glucosinolate Degradation Products Formed During Domestic Boiling of Cabbage
    Holger Hoffmann, Christiane Ott, Jana Raupbach, Lars Andernach, Matthias Renz, Tilman Grune, Franziska Sabine Hanschen · 2022 · Frontiers in Nutrition
13. Role of microRNAs in the pathogenesis of chronic obstructive pulmonary disease (COPD)
    Griet Conickx · 2017 · Ghent University Academic Bibliography (Ghent University)
14. Adenine Nucleotide Translocase as a Regulator of Chronic Obstructive Pulmonary Disease and Cytoskeletal Function
    Jennifer M. K. Nguyen · 2021
15. O6‐4: Treatment outcomes of COVID‐19 patients in Hong Kong's first designated infection control centre and the impact of emergent SARS‐CoV‐2 mutant strains from imported cases
    2021 · Respirology
16. Mitochondria and allergo-inflammation
    Fatemeh Javan, Mohadeseh Mohammad Taheri, Mohadeseh Poudineh, Akefeh Ahmadiafshar, Seyyed Shamsadin Athari · 2025 · Elsevier eBooks
17. Additional file 1 of Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder
    Andrew W. Zimmerman, Kanwaljit Singh, Susan L. Connors, Liu, Hua, Anita A. Panjwani, Lee, Li-Ching, Eileen Diggins, Foley, Ann, Melnyk, Stepan, Indrapal N. Singh et al. · 2021 · Figshare
18. Natural products as potential therapeutic candidates against chronic obstructive pulmonary disease
    Lintao Xu, Yong Li, Tao Shen · 2026 · Elsevier eBooks
19. Mechanism of Action and Therapeutic Potential of Sulforaphane in Skeletal Muscle Diseases: Molecular Pathways and Precision Medicine
    Minru Zhao, Bo Huang, Juan Chen, J W Li, Zhongli Zhu, Guoyun Zhu, Jian Hu, Fuxiang Li, Jian Feng · 2026 · Food Science & Nutrition
20. Nuclear factor erythroid 2-related factor 2 as targets to treat chronic obstructive pulmonary disease: toward new perspectives
    Haotian Chu, Xuejie Shao, Di Zhao, Peng Zhao, Ruilong Lu, Chen Wang, Yange Tian, Lanxi Zhang · 2026 · Therapeutic Advances in Respiratory Disease
21. Oxidative stress-driven epigenetic reprogramming of immune cells in COPD: from epitranscriptomic and metabolic crosstalk to treatable traits
    Chun Feng Pan, Qiong Wan, Feng-Xian Ni, Pan Xu, Donghui Huang, Zebo Jiang · 2026 · Frontiers in Immunology
22. Alveolar Macrophages: Development, Respiratory Homeostasis, Signal Pathways, Diseases, and Therapeutic Opportunities
    Sihan Yang, Ruomeng Li, Chuanjiang Yu, Jing Li, Xikun Zhou · 2026 · MedComm
23. Endoplasmic Reticulum Stress, Redox Signaling, and Neutrophil Effector Functions in Chronic Lung Diseases: Evidence and Research Priorities.
    Su Bin Park, T. Yook, M. U. Ur Rashid, Kangwook Lee, Jong Uk Kim, Dae Yong Kim, Mi Hye Kim, Ji-Yong Jang, Gabsik Yang · 2026 · Free Radical Biology & Medicine
24. Crosstalk Between the NRF2 Signaling Pathway and Heat Shock Proteins: Implications for Cellular Stress Response and Disease Therapy
    Milad Faraji, Saeed Nazıfı · 2026 · Oxidative Medicine and Cellular Longevity
25. BindingDB Entry 50009377: Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs).
    BindingDB · 2021 · UC San Diego